Post-treatment neutrophil-to-lymphocyte ratio (NLR) predicts response to anti-PD-1/PD-L1 antibody in SCLC patients at early phaseQi Xiong, Yi Hu, Guoqing Zhang et al.|Cancer Immunology Immunotherapy|2020Cited by 73
Lysosome Targeting Chimaeras for Glut1-Facilitated Targeted Protein DegradationJinyan Luo, Jin Geng, Ghada E. Khedr et al.|Journal of the American Chemical Society|2024Cited by 47